Showing results (681-690 of 1,725) with videos related to
Sort By:
Pageof 173
Drugs of Today (Barcelona, Spain : 1998)|November 7, 2014
A report from the American Society for Bone and Mineral Research 2014 Annual Meeting (September 12-15 - Houston, Texas, USA)X RabassedaDrugs of Today (Barcelona, Spain : 1998)|November 7, 2014
A report from the 50th Annual Meeting of the European Association for the Study of Diabetes (EASD) (September 15-19, 2014 - Vienna, Austria)D NavarroDrugs of Today (Barcelona, Spain : 1998)|November 14, 2019
Risankizumab.rzaa: an interleukin monoclonal antibody antagonist binding to the p19 subunit of human IL-23 cytokineD M PatonDrugs of Today (Barcelona, Spain : 1998)|December 17, 2019
Eptinezumab for the treatment of migraineD Scuteri, M T Corasaniti, P Tonin, et al.Drugs of Today (Barcelona, Spain : 1998)|December 17, 2019
Fexinidazole for the treatment of human African trypanosomiasisA H FairlambDrugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's diseaseD M PatonDrugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Mirogabalin besylate in the treatment of neuropathic painJ Burgess, S Javed, B Frank, et al.Drugs of Today (Barcelona, Spain : 1998)|February 15, 2020
The year's new drugs and biologics 2019A I Graul, P Pina, M Tracy, et al.Drugs of Today (Barcelona, Spain : 1998)|January 17, 2020
Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasmA Tandon, Y Zhang, L SokolDrugs of Today (Barcelona, Spain : 1998)|January 17, 2020
Triclabendazole for the treatment of fascioliasisR Thakare, A Dasgupta, S ChopraPageof 173